MULTICENTER RETROSPECTIVE ANALYSIS OF THE EFFICACY OF REGORAFENIB AFTER PROGRESSION ON SORAFENIB WITH HEPATOCELLULAR CARCINOMA

被引:0
|
作者
Lee, Min-Jin [1 ]
Chang, Sung Won [1 ]
Lee, Ha Seok [1 ]
Kim, Sehwa [1 ]
Lee, Young-Sun [1 ]
Jung, Young Kul [1 ]
Suh, Sang Jun [1 ]
Kim, Ji Hoon [1 ]
Seo, Yeon Seok [1 ]
Yim, Hyung Joon [1 ]
Yeon, Jong Eun [1 ]
Byun, Kwan Soo [1 ]
机构
[1] Korea Univ, Coll Med, Dept Internal Med, Seoul, South Korea
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
377
引用
收藏
页码:239A / 240A
页数:2
相关论文
共 50 条
  • [1] Multicenter retrospective analysis of the safety and efficacy of regorafenib after progression on sorafenib in Korean patients with hepatocellular carcinoma
    Yoo, Changhoon
    Park, Joong-Won
    Kim, Yoon Jun
    Kim, Do Young
    Yu, Su Jong
    Lim, Tae Seop
    Lee, Su Jin
    Ryoo, Baek-Yeol
    Lim, Ho Yeong
    [J]. INVESTIGATIONAL NEW DRUGS, 2019, 37 (03) : 567 - 572
  • [2] Multicenter retrospective analysis of the safety and efficacy of regorafenib after progression on sorafenib in Korean patients with hepatocellular carcinoma
    Changhoon Yoo
    Joong-Won Park
    Yoon Jun Kim
    Do Young Kim
    Su Jong Yu
    Tae Seop Lim
    Su Jin Lee
    Baek-Yeol Ryoo
    Ho Yeong Lim
    [J]. Investigational New Drugs, 2019, 37 : 567 - 572
  • [3] Efficacy and safety of regorafenib after progression on sorafenib in Korean patients with advanced hepatocellular carcinoma (HCC)
    Yoo, C.
    Park, J-W.
    Kim, Y. J.
    Kim, D. Y.
    Yu, S. J.
    Lim, T. S.
    Ryoo, B-Y.
    Lee, S. J.
    Lim, H-Y.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [4] Regorafenib Efficacy After Sorafenib in Patients With Recurrent Hepatocellular Carcinoma After Liver Transplantation: A Retrospective Study
    Iavarone, Massimo
    Invernizzi, Federica
    Ivanics, Tommy
    Mazza, Stefano
    Zavaglia, Claudio
    Sanduzzi-Zamparelli, Marco
    Fraile-Lopez, Miguel
    Czauderna, Carolin
    Di Costanzo, Giovanni
    Bhoori, Sherrie
    Pinter, Matthias
    Manini, Matteo Angelo
    Amaddeo, Giuliana
    Fernandez Yunquera, Ainhoa
    Pinero, Federico
    Blanco Rodriguez, Maria Jose
    Anders, Margarita
    Aballay Soteras, Gabriel
    Villadsen, Gerda Elisabeth
    Yoon, Peter Daechul
    Cesarini, Lucia
    Diaz-Gonzalez, Alvaro
    Luisa Gonzalez-Dieguez, Maria
    Tortora, Raffaella
    Weinmann, Arndt
    Mazzaferro, Vincenzo
    Romero Cristobal, Mario
    Crespo, Gonzalo
    Regnault, Helene
    De Giorgio, Massimo
    Varela, Maria
    Prince, Rebecca
    Scudeller, Luigia
    Donato, Maria Francesca
    Worns, Marcus-Alexander
    Bruix, Jordi
    Sapisochin, Gonzalo
    Lampertico, Pietro
    Reig, Maria
    [J]. LIVER TRANSPLANTATION, 2021, 27 (12) : 1767 - 1778
  • [5] Sequential therapy with sorafenib and regorafenib for advanced hepatocellular carcinoma: a multicenter retrospective study in Japan
    Sadahisa Ogasawara
    Yoshihiko Ooka
    Norio Itokawa
    Masanori Inoue
    Shinichiro Okabe
    Atsuyoshi Seki
    Yuki Haga
    Masamichi Obu
    Masanori Atsukawa
    Ei Itobayashi
    Hideaki Mizumoto
    Nobuyuki Sugiura
    Ryosaku Azemoto
    Kengo Kanayama
    Hiroaki Kanzaki
    Susumu Maruta
    Takahiro Maeda
    Yuko Kusakabe
    Masayuki Yokoyama
    Kazufumi Kobayashi
    Soichiro Kiyono
    Masato Nakamura
    Tomoko Saito
    Eiichiro Suzuki
    Shingo Nakamoto
    Shin Yasui
    Akinobu Tawada
    Tetsuhiro Chiba
    Makoto Arai
    Tatsuo Kanda
    Hitoshi Maruyama
    Naoya Kato
    [J]. Investigational New Drugs, 2020, 38 : 172 - 180
  • [6] Sequential therapy with sorafenib and regorafenib for advanced hepatocellular carcinoma: a multicenter retrospective study in Japan
    Ogasawara, Sadahisa
    Ooka, Yoshihiko
    Itokawa, Norio
    Inoue, Masanori
    Okabe, Shinichiro
    Seki, Atsuyoshi
    Haga, Yuki
    Obu, Masamichi
    Atsukawa, Masanori
    Itobayashi, Ei
    Mizumoto, Hideaki
    Sugiura, Nobuyuki
    Azemoto, Ryosaku
    Kanayama, Kengo
    Kanzaki, Hiroaki
    Maruta, Susumu
    Maeda, Takahiro
    Kusakabe, Yuko
    Yokoyama, Masayuki
    Kobayashi, Kazufumi
    Kiyono, Soichiro
    Nakamura, Masato
    Saito, Tomoko
    Suzuki, Eiichiro
    Nakamoto, Shingo
    Yasui, Shin
    Tawada, Akinobu
    Chiba, Tetsuhiro
    Arai, Makoto
    Kanda, Tatsuo
    Maruyama, Hitoshi
    Kato, Naoya
    [J]. INVESTIGATIONAL NEW DRUGS, 2020, 38 (01) : 172 - 180
  • [7] Safety and efficacy of sorafenib followed by regorafenib or lenvatinib in patients with hepatocellular carcinoma
    Terashima, Takeshi
    Yamashita, Tatsuya
    Takata, Noboru
    Takeda, Yasuhito
    Kido, Hidenori
    Iida, Noriho
    Kitahara, Masaaki
    Shimakami, Tetsuro
    Takatori, Hajime
    Arai, Kuniaki
    Kawaguchi, Kazunori
    Kitamura, Kazuya
    Yamashita, Taro
    Sakai, Yoshio
    Mizukoshi, Eishiro
    Honda, Masao
    Kaneko, Shuichi
    [J]. HEPATOLOGY RESEARCH, 2021, 51 (02) : 190 - 200
  • [8] Nivolumab Versus Regorafenib in Patients With Hepatocellular Carcinoma After Sorafenib Failure
    Kuo, Yuan-Hung
    Yen, Yi-Hao
    Chen, Yen-Yang
    Kee, Kwong-Ming
    Hung, Chao-Hung
    Lu, Sheng-Nan
    Hu, Tsung-Hui
    Chen, Chien-Hung
    Wang, Jing-Houng
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [9] Real-world systemic sequential therapy with sorafenib and regorafenib for advanced hepatocellular carcinoma: a multicenter retrospective study in Korea
    Lee, Min Jin
    Chang, Sung Won
    Kim, Ji Hoon
    Lee, Young-Sun
    Cho, Sung Bum
    Seo, Yeon Seok
    Yim, Hyung Joon
    Hwang, Sang Youn
    Lee, Hyun Woong
    Chang, Young
    Jang, Jae Young
    [J]. INVESTIGATIONAL NEW DRUGS, 2021, 39 (01) : 260 - 268
  • [10] Real-world systemic sequential therapy with sorafenib and regorafenib for advanced hepatocellular carcinoma: a multicenter retrospective study in Korea
    Min Jin Lee
    Sung Won Chang
    Ji Hoon Kim
    Young-Sun Lee
    Sung Bum Cho
    Yeon Seok Seo
    Hyung Joon Yim
    Sang Youn Hwang
    Hyun Woong Lee
    Young Chang
    Jae Young Jang
    [J]. Investigational New Drugs, 2021, 39 : 260 - 268